Evidence map›Paper›PMID 32404334›Full record

ArticleJournal of lipid research2020

15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5.

Steven C Perry, Chakrapani Kalyanaraman, Benjamin E Tourdot, William S Conrad, Oluwayomi Akinkugbe, John Cody Freedman, Michael Holinstat, Matthew P Jacobson, Theodore R Holman

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genetic Markers of Postmortem Brain Iron.Journal of neurochemistry · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. OralFrontiers in microbiology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Steven C PerryDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.
Chakrapani KalyanaramanDepartment of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143.
Benjamin E TourdotDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109.
William S ConradDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.
Oluwayomi AkinkugbeDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.
John Cody FreedmanDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.
Michael HolinstatDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109.
Matthew P JacobsonDepartment of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143.
Theodore R HolmanDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064. Electronic address: mailto:holman@ucsc.edu.
University of California, Santa Cruz · USUniversity of California, San Francisco · USUniversity of Michigan · US

Funding

12-HETrE regulation of blood coagulation, hemostasis, and thrombosisR35GM131835 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLINSTAT, MICHAEL ALLAN · 2019 to 2023
$2.3M
Elucidating the phenome-wide impact of sex and gender on diseaseR01HG011405 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DAVIS, LEA K, STRANGER, BARBARA E · 2021 to 2024
$1.9M
12-HETrE regulation of plateletsR01GM105671 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLINSTAT, MICHAEL ALLAN · 2013 to 2017
$1.6M
The racial disparity in platelet PAR4 signaling enhances thrombus formationR00HL136784 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI TOURDOT, BENJAMIN ERIC · 2020 to 2022
$747k
The racial disparity in platelet PAR4 signaling enhances thrombus formationK99HL136784 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TOURDOT, BENJAMIN ERIC · 2018 to 2019
$202k
NHGRI NIH HHS R01 HG011405NHLBI NIH HHS K99 HL136784NHLBI NIH HHS R00 HL136784NIGMS NIH HHS R01 GM105671NIGMS NIH HHS R35 GM131835
6 · The paper itself

Abstract

The two oxylipins 7S,14S-dihydroxydocosahexaenoic acid (diHDHA) and 7S,17S-diHDHA [resolvin D5 (RvD5)] have been found in macrophages and infectious inflammatory exudates and are believed to function as specialized pro-resolving mediators (SPMs). Their biosynthesis is thought to proceed through sequential oxidations of DHA by lipoxygenase (LOX) enzymes, specifically, by human 5-LOX (h5-LOX) first to 7(S)-hydroxy-4Z,8E,10Z,13Z,16Z,19Z-DHA (7S-HDHA), followed by human platelet 12-LOX (h12-LOX) to form 7(S),14(S)-dihydroxy-4Z,8E,10Z,12E,16Z,19Z-DHA (7S,14S-diHDHA) or human reticulocyte 15-LOX-1 (h15-LOX-1) to form RvD5. In this work, we determined that oxidation of 7(S)-hydroperoxy-4Z,8E,10Z,13Z,16Z,19Z-DHA to 7S,14S-diHDHA is performed with similar kinetics by either h12-LOX or h15-LOX-1. The oxidation at C14 of DHA by h12-LOX was expected, but the noncanonical reaction of h15-LOX-1 to make over 80% 7S,14S-diHDHA was larger than expected. Results of computer modeling suggested that the alcohol on C7 of 7S-HDHA hydrogen bonds with the backbone carbonyl of Ile399, forcing the hydrogen abstraction from C12 to oxygenate on C14 but not C17. This result raised questions regarding the synthesis of RvD5. Strikingly, we found that h15-LOX-2 oxygenates 7S-HDHA almost exclusively at C17, forming RvD5 with faster kinetics than does h15-LOX-1. The presence of h15-LOX-2 in neutrophils and macrophages suggests that it may have a greater role in biosynthesizing SPMs than previously thought. We also determined that the reactions of h5-LOX with 14(S)-hydroperoxy-4Z,7Z,10Z,12E,16Z,19Z-DHA and 17(S)-hydroperoxy-4Z,7Z,10Z,13Z,15E,19Z-DHA are kinetically slow compared with DHA, suggesting that these reactions may be minor biosynthetic routes in vivo. Additionally, we show that 7S,14S-diHDHA and RvD5 have anti-aggregation properties with platelets at low micromolar potencies, which could directly regulate clot resolution.

Indexed as

Arachidonate 15-LipoxygenaseBlood PlateletsDocosahexaenoic AcidsHumansArachidonate 15-LipoxygenaseDocosahexaenoic Acidsresolvin D57-hydroxydocosahexaenoic acid7(S),14(S)-dihydroxy-4Z,8E,10Z,12E,16Z,19Z-docosahexaenoic aciddocosahexaenoic acidenzymologyhuman reticulocyte 15-lipoxygenase-1kineticsmaresinmass spectrometrymolecular modelingomega-3 fatty acidplatelets

Identifiers

PMID32404334
PMCPMC7328043
OpenAlexW3024066838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.